Powered by

Powered by Portfolio Grader

Eagle Pharmaceutical (EGRX)

52.72 1.00 (1.93%) 16:41 EDT
EGRX Stock Quote Delayed 15 Minutes
  • EGRX Stock Chart

  • Historical EGRX Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       26.10
Market Cap:       782.12M
EPS:       2.02
Volume:       168,400
Day's Range:       49.98 - 53.20
52wk Range:       36.03 - 85.66
Quotes delayed at least 20 mins.
Historical Data for EGRX
Date Open High Low Volume Close Change %
04/25/19 51.54 53.20 49.98 168,463 52.72 1.00   1.93%
04/24/19 52.16 52.78 51.44 160,121 51.72 -0.32   -0.61%
04/23/19 49.06 52.15 49.02 277,977 52.04 3.50   7.21%
04/22/19 47.69 48.67 46.57 188,836 48.54 0.73   1.53%
04/18/19 47.16 48.36 46.25 237,200 47.81 0.70   1.49%
04/17/19 49.80 50.02 46.98 283,561 47.11 -2.89   -5.78%
04/16/19 47.90 50.07 47.56 238,835 50.00 2.49   5.24%
04/15/19 46.75 47.73 44.71 138,291 47.51 0.83   1.78%
04/12/19 47.65 48.14 46.13 184,600 46.68 -0.57   -1.21%
04/11/19 47.81 48.03 46.47 149,355 47.25 -0.46   -0.96%
04/10/19 46.80 47.76 46.37 174,030 47.71 1.10   2.36%
04/09/19 49.19 49.26 46.45 149,189 46.61 -2.62   -5.32%
04/08/19 48.56 49.49 47.81 247,529 49.23 0.54   1.11%
04/05/19 50.36 50.61 48.27 197,800 48.69 -1.51   -3.01%
04/04/19 49.91 51.84 49.65 236,235 50.20 0.09   0.18%
04/03/19 51.15 51.31 49.73 143,764 50.11 -0.61   -1.20%
04/02/19 50.24 51.15 49.76 84,683 50.72 0.54   1.08%
04/01/19 50.85 50.86 49.75 174,991 50.18 -0.31   -0.61%
03/29/19 50.43 51.34 49.79 154,100 50.49 0.49   0.98%
03/28/19 49.12 50.95 49.10 96,274 50.00 1.00   2.04%
03/27/19 49.20 49.68 48.00 111,581 49.00 -0.14   -0.28%
03/26/19 48.88 49.68 48.19 120,806 49.14 0.72   1.49%
03/25/19 47.21 48.90 46.65 116,546 48.42 1.27   2.69%
03/22/19 50.51 50.52 47.11 196,200 47.15 -3.47   -6.85%
03/21/19 47.64 51.05 47.64 198,968 50.62 2.73   5.70%
03/20/19 48.87 49.36 47.83 104,562 47.89 -0.96   -1.97%
03/19/19 49.38 49.87 48.76 148,729 48.85 -0.32   -0.65%
03/18/19 47.02 49.38 46.92 156,393 49.17 2.15   4.57%
03/15/19 47.46 48.37 46.80 824,000 47.02 -0.31   -0.65%
03/14/19 48.16 48.65 47.18 114,497 47.33 -0.88   -1.83%
03/13/19 48.20 48.62 47.70 113,559 48.21 0.07   0.15%
03/12/19 48.19 48.74 47.32 108,034 48.14 0.25   0.52%
03/11/19 47.67 48.18 46.08 170,549 47.89 0.22   0.46%
03/08/19 47.37 48.06 46.69 151,400 47.67 0.10   0.21%
03/07/19 47.94 48.49 46.84 141,159 47.57 -0.38   -0.79%
03/06/19 48.90 48.90 47.44 184,142 47.95 -0.80   -1.64%
03/05/19 49.08 50.21 48.20 177,556 48.75 -0.32   -0.65%
03/04/19 52.07 52.30 48.52 225,572 49.07 -2.75   -5.31%
03/01/19 50.29 52.84 50.10 300,100 51.82 1.75   3.50%
02/28/19 50.04 51.09 48.30 327,900 50.07 1.25   2.56%
02/27/19 46.45 48.93 45.54 277,276 48.82 2.08   4.45%
02/26/19 47.52 47.79 46.74 350,033 46.74 -1.05   -2.20%
02/25/19 46.89 47.91 46.12 386,293 47.79 1.56   3.37%
02/22/19 45.23 46.24 44.92 341,800 46.23 0.99   2.19%
02/21/19 44.76 46.69 44.04 728,896 45.24 1.87   4.31%
02/20/19 41.90 43.42 41.51 160,749 43.37 1.53   3.66%
02/19/19 41.84 42.57 41.52 99,257 41.84 -0.06   -0.14%
02/15/19 40.66 42.14 40.66 159,100 41.90 1.37   3.38%
02/14/19 39.23 40.53 38.72 239,466 40.53 1.00   2.53%
02/13/19 39.49 40.70 39.12 188,205 39.53 0.19   0.48%
02/12/19 38.83 39.99 38.44 238,247 39.34 0.68   1.76%
02/11/19 39.64 39.90 38.38 110,402 38.66 -0.81   -2.05%
02/08/19 39.21 40.39 38.80 162,100 39.47 0.20   0.51%
02/07/19 40.86 41.12 39.17 118,604 39.27 -1.78   -4.34%
02/06/19 41.36 41.65 40.56 116,507 41.05 -0.36   -0.87%
02/05/19 42.21 43.71 41.32 174,306 41.41 -1.02   -2.40%
Eagle Pharmaceutical (EGRX) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Eagle Pharmaceutical Stock Analysis

Rating: Hold

Total Grade: C

Analysis Breakdown

EGRX Stock Grade: C
Fundamental Grade: B
Quantitative Grade: C
EGRX Earnings
Earnings Growth: B
Earnings Momentum: B
Earnings Surprises: C
Analyst Earnings Revisions: D
EGRX Financial Information
Sales Growth: B
Operating Margin Growth: B
Cash Flow: B
Return on Equity: A

Eagle Pharmaceutical Stock: Weekly View

This Week: C
Last Week: C
Two Weeks Ago: C
Get Full Report